A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.
Gao F, Yao Q, Zhu J, Chen W, Feng X, Feng B, Wu J, Pacak K, Rosenblum J, Yu J, Zhuang Z, Cao H, Li L.
Gao F, et al.
Pharmacol Res. 2023 Aug;194:106851. doi: 10.1016/j.phrs.2023.106851. Epub 2023 Jul 13.
Pharmacol Res. 2023.
PMID: 37453673
Free PMC article.